Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cathepsin B | 8 | 2022 | 29 | 4.890 |
Why?
|
| Macrophages | 11 | 2022 | 431 | 3.840 |
Why?
|
| HIV Infections | 14 | 2022 | 2207 | 2.230 |
Why?
|
| HIV-1 | 11 | 2022 | 678 | 1.970 |
Why?
|
| AIDS Dementia Complex | 6 | 2018 | 107 | 1.580 |
Why?
|
| Proteomics | 6 | 2017 | 302 | 1.310 |
Why?
|
| Apoptosis | 7 | 2022 | 1317 | 1.100 |
Why?
|
| Neurons | 5 | 2022 | 1130 | 1.100 |
Why?
|
| Proteome | 3 | 2021 | 132 | 1.100 |
Why?
|
| Cognition Disorders | 6 | 2017 | 233 | 1.100 |
Why?
|
| Monocytes | 6 | 2013 | 258 | 0.840 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2022 | 33 | 0.830 |
Why?
|
| Antioxidants | 2 | 2018 | 386 | 0.820 |
Why?
|
| Cannabinoids | 1 | 2022 | 54 | 0.800 |
Why?
|
| Cystatin B | 3 | 2022 | 8 | 0.800 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 99 | 0.740 |
Why?
|
| Ethylenediamines | 1 | 2018 | 6 | 0.680 |
Why?
|
| Receptors, sigma | 1 | 2018 | 16 | 0.670 |
Why?
|
| Cocaine | 2 | 2018 | 219 | 0.670 |
Why?
|
| Anabolic Agents | 1 | 2017 | 17 | 0.610 |
Why?
|
| Androgens | 1 | 2017 | 87 | 0.590 |
Why?
|
| Hypothalamus | 1 | 2017 | 122 | 0.580 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 84 | 0.480 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 182 | 0.470 |
Why?
|
| Humans | 22 | 2022 | 34853 | 0.460 |
Why?
|
| Female | 17 | 2022 | 19873 | 0.440 |
Why?
|
| Placenta | 2 | 2022 | 91 | 0.410 |
Why?
|
| Cerebrospinal Fluid | 2 | 2007 | 18 | 0.400 |
Why?
|
| Virus Replication | 3 | 2022 | 261 | 0.390 |
Why?
|
| HIV Core Protein p24 | 2 | 2018 | 10 | 0.340 |
Why?
|
| Catalase | 1 | 2008 | 106 | 0.330 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 109 | 0.330 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 149 | 0.320 |
Why?
|
| Cells, Cultured | 3 | 2017 | 1442 | 0.310 |
Why?
|
| Cohort Studies | 5 | 2017 | 1422 | 0.300 |
Why?
|
| Pregnancy | 2 | 2022 | 1503 | 0.300 |
Why?
|
| Cell Line | 2 | 2018 | 1289 | 0.250 |
Why?
|
| Adult | 11 | 2015 | 11034 | 0.240 |
Why?
|
| Profilins | 1 | 2022 | 2 | 0.220 |
Why?
|
| Analysis of Variance | 2 | 2017 | 528 | 0.210 |
Why?
|
| Oxidative Stress | 2 | 2018 | 874 | 0.210 |
Why?
|
| Serum Amyloid P-Component | 1 | 2022 | 20 | 0.210 |
Why?
|
| Fibrinogen | 1 | 2021 | 23 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 68 | 0.200 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2010 | 79 | 0.200 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 111 | 0.190 |
Why?
|
| Viral Load | 3 | 2013 | 300 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 160 | 0.180 |
Why?
|
| Middle Aged | 8 | 2015 | 9642 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 255 | 0.180 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 38 | 0.170 |
Why?
|
| Reactive Nitrogen Species | 1 | 2018 | 10 | 0.170 |
Why?
|
| Morpholines | 1 | 2018 | 65 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2018 | 126 | 0.160 |
Why?
|
| Inflammation | 1 | 2022 | 577 | 0.160 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 841 | 0.160 |
Why?
|
| Caspase 3 | 1 | 2018 | 194 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2022 | 653 | 0.160 |
Why?
|
| Microwaves | 1 | 2017 | 26 | 0.160 |
Why?
|
| Magnetics | 1 | 2017 | 36 | 0.150 |
Why?
|
| Mice | 2 | 2018 | 5668 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2017 | 834 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 102 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 140 | 0.140 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2015 | 219 | 0.140 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 859 | 0.140 |
Why?
|
| Apolipoprotein C-III | 1 | 2015 | 6 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 416 | 0.140 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 44 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 173 | 0.140 |
Why?
|
| Synapses | 1 | 2017 | 173 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 984 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 2128 | 0.120 |
Why?
|
| Basal Ganglia | 1 | 2012 | 17 | 0.110 |
Why?
|
| Cystatin C | 1 | 2012 | 21 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2012 | 35 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2013 | 295 | 0.110 |
Why?
|
| Lysosomes | 1 | 2012 | 80 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 392 | 0.100 |
Why?
|
| Lymphocytes | 2 | 2013 | 116 | 0.100 |
Why?
|
| Animals | 2 | 2018 | 14307 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 153 | 0.100 |
Why?
|
| Brain | 1 | 2018 | 1268 | 0.100 |
Why?
|
| Immunologic Techniques | 1 | 2010 | 10 | 0.100 |
Why?
|
| Peroxiredoxins | 1 | 2010 | 10 | 0.100 |
Why?
|
| Disease Progression | 1 | 2013 | 580 | 0.100 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 64 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 100 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 490 | 0.090 |
Why?
|
| Peroxidase | 1 | 2010 | 50 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 65 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2010 | 43 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2561 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2007 | 255 | 0.090 |
Why?
|
| Cognition | 1 | 2012 | 373 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2008 | 151 | 0.080 |
Why?
|
| Hippocampus | 1 | 2012 | 546 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 4012 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1490 | 0.080 |
Why?
|
| Receptors, CCR5 | 1 | 2007 | 59 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2007 | 67 | 0.070 |
Why?
|
| Glioma | 1 | 2007 | 76 | 0.070 |
Why?
|
| Virulence | 1 | 2007 | 221 | 0.070 |
Why?
|
| Transfection | 1 | 2007 | 496 | 0.070 |
Why?
|
| Phenotype | 1 | 2007 | 650 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 26 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 600 | 0.060 |
Why?
|
| United States | 1 | 2013 | 3894 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2008 | 1961 | 0.060 |
Why?
|
| Smoking | 1 | 2007 | 903 | 0.050 |
Why?
|
| Oxygen Isotopes | 1 | 2015 | 6 | 0.040 |
Why?
|
| Puerto Rico | 2 | 2013 | 1352 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 60 | 0.030 |
Why?
|
| Male | 2 | 2013 | 18870 | 0.030 |
Why?
|
| Complement C3 | 1 | 2007 | 15 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 185 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 195 | 0.020 |
Why?
|
| Hawaii | 1 | 2013 | 1878 | 0.020 |
Why?
|
| Women's Health | 1 | 2007 | 135 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2006 | 7 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 173 | 0.020 |
Why?
|
| Memory | 1 | 2006 | 165 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1124 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 1425 | 0.010 |
Why?
|